Your browser doesn't support javascript.
loading
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand, Douglas H; Tree, Alison C; Ostler, Peter; van der Voet, Hans; Loblaw, Andrew; Chu, William; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Martin, Alexander; Staffurth, John; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Dayes, Ian S; Henderson, Daniel; Brown, Stephanie; Cruickshank, Clare; Burnett, Stephanie; Duffton, Aileen; Griffin, Clare; Hinder, Victoria; Morrison, Kirsty; Naismith, Olivia; Hall, Emma; van As, Nicholas.
Afiliación
  • Brand DH; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.
  • Tree AC; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.
  • Ostler P; Mount Vernon Cancer Centre, Northwood, UK.
  • van der Voet H; The James Cook University Hospital, Middlesbrough, UK.
  • Loblaw A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Ford D; University Hospitals Birmingham, Birmingham, UK.
  • Tolan S; The Clatterbridge Cancer Centre, Birkenhead, UK.
  • Jain S; Queen's University Belfast, Belfast, UK.
  • Martin A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Staffurth J; Cardiff University, Cardiff, UK.
  • Camilleri P; Churchill Hospital, Oxford, UK.
  • Kancherla K; University Hospitals of Leicester, Leicester, UK.
  • Frew J; Freeman Hospital, Newcastle, UK.
  • Chan A; University Hospitals Coventry & Warwickshire, Coventry, UK.
  • Dayes IS; Department of Oncology, McMaster University, Hamilton, ON, Canada.
  • Henderson D; University Hospitals Birmingham, Birmingham, UK.
  • Brown S; The Institute of Cancer Research, London, UK.
  • Cruickshank C; The Institute of Cancer Research, London, UK.
  • Burnett S; The Institute of Cancer Research, London, UK.
  • Duffton A; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Griffin C; The Institute of Cancer Research, London, UK.
  • Hinder V; The Institute of Cancer Research, London, UK.
  • Morrison K; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.
  • Naismith O; The Royal Marsden Hospital, London, UK.
  • Hall E; The Institute of Cancer Research, London, UK.
  • van As N; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK. Electronic address: nicholas.vanas@rmh.nhs.uk.
Lancet Oncol ; 20(11): 1531-1543, 2019 11.
Article en En | MEDLINE | ID: mdl-31540791
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Adenocarcinoma / Radiocirugia / Radioterapia de Intensidad Modulada / Hipofraccionamiento de la Dosis de Radiación Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Aged / Humans / Male País/Región como asunto: America do norte / Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Adenocarcinoma / Radiocirugia / Radioterapia de Intensidad Modulada / Hipofraccionamiento de la Dosis de Radiación Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Aged / Humans / Male País/Región como asunto: America do norte / Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido